Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Faber

Showing results (191-200 of 195) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 195 results.
Cancer Cell|February 10, 2016
Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy CombinationJungoh Ham, Carlotta Costa, Renata Sano, et al.
Research Square|June 17, 2024
Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial SarcomaKonstantinos V Floros, Carter K Fairchild, Jinxiu Li, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial SarcomaKonstantinos V Floros, Carter K Fairchild, Jinxiu Li, et al.
Nature Communications|November 5, 2025
Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcomaKonstantinos V Floros, Carter K Fairchild, Jinxiu Li, et al.
British Journal of Cancer|September 5, 2001
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' studyH J Andreyev, A R Norman, D Cunningham, et al.
Pageof 20

Showing results (191-200 of 195) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 195 results.
Cancer Cell|February 10, 2016
Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy CombinationJungoh Ham, Carlotta Costa, Renata Sano, et al.
Research Square|June 17, 2024
Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial SarcomaKonstantinos V Floros, Carter K Fairchild, Jinxiu Li, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial SarcomaKonstantinos V Floros, Carter K Fairchild, Jinxiu Li, et al.
Nature Communications|November 5, 2025
Targeting SUMOylation promotes cBAF complex stabilization and disruption of the SS18::SSX transcriptome in synovial sarcomaKonstantinos V Floros, Carter K Fairchild, Jinxiu Li, et al.
British Journal of Cancer|September 5, 2001
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' studyH J Andreyev, A R Norman, D Cunningham, et al.
Pageof 20